中文版 | English

个人主页

关键词云

成果统计

合作作者[TOP 5]

  • 蒋华良

    合作成果数：8

  • 谢成英

    合作成果数：8

  • 赵昱

    合作成果数：4

  • Shen, Jie

    合作成果数：4

  • 凌丽君

    合作成果数：3

访问统计


  总访问量
 787
  访问来源
    内部： 3
    外部： 784
    国内： 692
    国外： 95

  年访问量
 141
  访问来源
    内部： 0
    外部： 141
    国内： 130
    国外： 11

  月访问量
 16
  访问来源
    内部： 0
    外部： 16
    国内： 13
    国外： 3

访问量

访问量

1. Discovery, structural optimization, and anti-tumor bioactivity eva.. [551]
2. 五环三萜衍生物的医药用途、五环三萜衍生物、包含其的药物组合物 [496]
3. Regulation of CCL2 by EZH2 affects tumor-associated macrophages po.. [491]
4. Mitochondrial metabolism regulates macrophage biology [439]
5. Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance th.. [375]
6. Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Rele.. [348]
7. BCL-2 inhibitor synergizes with PI3Kδ inhibitor and overcomes FLT.. [327]
8. 143D, a novel selective KRASG12C inhibitor exhibits potent antitum.. [325]
9. BCL-2 inhibitor synergizes with PI3K delta inhibitor and overcomes.. [178]
10. Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity a.. [167]
11. Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity a.. [93]
12. IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inh.. [77]

下载量

1. Regulation of CCL2 by EZH2 affects tumor-associated macrophages po.. [178]
2. Discovery, structural optimization, and anti-tumor bioactivity eva.. [8]
3. Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity a.. [7]
4. Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance th.. [5]
5. 143D, a novel selective KRASG12C inhibitor exhibits potent antitum.. [4]
6. Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity a.. [4]
7. Mitochondrial metabolism regulates macrophage biology [3]
8. IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inh.. [3]
9. Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Rele.. [2]
10. BCL-2 inhibitor synergizes with PI3Kδ inhibitor and overcomes FLT.. [1]
11. BCL-2 inhibitor synergizes with PI3K delta inhibitor and overcomes.. [1]
12. 五环三萜衍生物的医药用途、五环三萜衍生物、包含其的药物组合物 [1]